Results 241 to 250 of about 106,036 (288)
Efficacy and safety of selective aldosterone synthase inhibitors in uncontrolled hypertension: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Clin HypertensLouat A +7 more
europepmc +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 935-945, February 2026.Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang +5 more
wiley +1 more source
Role of Ethnicity and Sex in Hypertension-Mediated Organ Damage in a Dual-Ethnic Cohort of Individuals With Hypertension. [PDF]
HypertensionHernandez-Rubio A +6 more
europepmc +1 more source
Genetic evidence for the causal relationship between metabolic diseases and primary aldosteronism: insights from Mendelian randomization analysis. [PDF]
Cardiovasc Endocrinol MetabZhang H, Lin Z, Tian W, Ma Z.
europepmc +1 more source
Unmasking Secondary Hypertension: Renal Artery Stenosis Concealing the Diagnosis of Primary Hyperaldosteronism. [PDF]
CureusWurtz PJ +4 more
europepmc +1 more source
Incidence of Adrenal Masses Eventually Discovered in Patients Screened for Primary Aldosteronism.
J Clin Endocrinol MetabKline GA +7 more
europepmc +1 more source